As a result, they’re more likely to develop X-linked conditions like Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy — the two most common types of the condition — if one of ...

Duchenne and Becker muscular dystrophy, as well as some types of Emery-Dreifuss muscular dystrophies, arise as a result of mutations on one of the X chromosomes carried by the female parent.

MicroRNA-33a and microRNA-33b are encoded within the mammalian SREBF1 and SRBF2 genes, respectively, and both SREBF1 and ...

Becker muscular dystrophy causes long-term disability and is life-threatening because of its effects on the heart. No therapies are currently approved for Becker muscular dystrophy in the United ...

Becker Muscular Dystrophy, much like Duchenne Muscular Dystrophy, is a type of genetic disorder that causes progressive muscle weakness and degeneration over time, primarily in males.

A father of two sons diagnosed with muscular dystrophy is organizing a cornhole tournament this weekend to raise money for ...

The symptoms of Becker muscular dystrophy are similar to those of Duchenne muscular dystrophy. But Becker muscular dystrophy starts later -- around the teen years. It also develops much more slowly.

In addition to papers on Muscular dystrophies: causes and treatment, Scientific Reports welcomes all original research in the field of diseases. To browse our latest articles in diseases click here .

Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are the two most common forms of the disease, representing 80% of all cases of muscular dystrophy. Both diseases almost ...

Tadalafil Alleviates Muscle Ischemia in Patients with Becker Muscular Dystrophy. Science Translational Medicine , 2012; 4 (162): 162ra155 DOI: 10.1126/scitranslmed.3004327 Cite This Page : ...

U.S. FDA grants Orphan Drug Designation to Deramiocel for the treatment of Becker Muscular Dystrophy, broadening Capricor’s focus in neuromuscular diseasesCapricor remains on track for the ...

Edgewise Therapeutics, Inc.,, a leading muscle disease biopharmaceutical company, today announced that the company will present data on sevasemten, an investigational orally administered first-in ...